• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Feds defend Obamacare

Feds defend Obamacare

March 1, 2011 By MassDevice staff

Healthcare reform

The Florida judge who overturned a portion of the Patient Protection & Affordable Care Act never meant to stop its implementation, according to federal lawyers looking to block a ban on President Barack Obama’ signature achievement to date.

Administration lawyers argued last night that the plaintiffs, 26 states and a trade group, challenged only Obamacare’s “individual mandate” for near-universal healthcare coverage beginning in 2014. Although Judge Roger Vinson of the U.S. District Court for Northern Florida agreed, he never addressed stopping the law’s implementation, according to court documents.

The plaintiffs argued that the judge clearly meant to do just that, prompting a sharp retort from Obama’s lawyers.

“Plaintiffs profess surprise at defendants’ ‘inexplicabl[e] delay’ in seeking this clarification but, at the same time, they continue to take advantage of numerous provisions of the Act that they did not challenge and that the Court did not address,” they wrote. “[S]ince the court entered its judgment on Jan. 31, at least 24 of the 26 plaintiff states have applied for additional grants authorized or appropriated by the [Affordable Care Act], continued to draw down grant funds previously awarded under the ACA, or otherwise availed themselves of resources made available by the ACA.

“Indeed, South Carolina has continued to drawn down exchange planning grant funds, even though it has declared the act ‘void and unenforceable.’ Similarly, Utah has described the declaratory judgment as an ‘injunction against further implementation’ of the act, but has continued to draw down … funds,” according to court documents.

Although the administration can claim to be ahead 3-2 in court challenges to its landmark achievement, after Judge Gladys Kessler of the U.S. District Court for the District of Columbia rejected a challenge last week, it might not matter in the long run.

That’s because all of the judges who have weighed in so far have agreed on one thing: The individual mandate is a penalty, not a tax. The matter, expected to land on the U.S. Supreme Court’s docket next year, could hinge on that distinction. Congress has the power to enact taxes, not penalties, leaving an opening for the Supremes to strike down the mandate and fatally wound Obamacare.

Beginning in 2014, Americans will have to prove they have health insurance or pay fines ranging from $95 to $695 by 2016 (or 2.5 percent of taxable income, whichever is greater).

Filed Under: Healthcare Reform, News Well

More recent news

  • Ambu wins FDA clearance for first single-use cysto-nephroscope
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy